About Berkeley
Berkeley is a venture capital firm founded in 2022. It is primarily based out of Berkeley, United States. As of Jan 2026, Berkeley is an active investor, having invested in 9 companies, with 3 new investments in the last 12 months. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Life Sciences. Most recently it participated in the $***** Seed round of Datalinx Overall, Berkeley portfolio has seen 2 unicorns and 1 acquisition, namely Ayar Labs, Neurona Therapeutics and Mammoth. A lot of funds co-invest with Berkeley, with names like IAG Capital Partners sharing a substantial percentage of its portfolio. Berkeley has team of 29 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 2 more
Portfolio Acquisitions
Berkeley's List of Top Investments
Berkeley has a portfolio of 9 companies, including 2 unicorns. Their most notable investments include Databricks and Ayar Labs.Their portfolio spans across and United States. They have invested in Enterprise Applications, High Tech, Life Sciences and 2 other sectors, across stages such as Seed, Series A and 2 more. Here is the list of top investments by Berkeley:
1. Databricks
Provider of a unified data and AI platform for building and managing analytical and operational workloads. This platform enables organizations to build business intelligence and artificial intelligence applications, stream and analyze data, and process daily operations with consistent security, performance, and governance. It integrates data engineering, data warehousing, and machine learning capabilities into a single foundation, allowing teams to build, deploy, and manage production applications.
Key facts about Databricks
- Founded Year: 2013
- Location: San Francisco (United States)
- Annual Revenue: $1B+ as on Dec 31, 2024
- Valuation: $*****
- Stage: Series L
- Total Funding till date: $25.2B
- Employee Count: 5,679 as on Dec 31, 2025
- Investors: equitywestsecurities.com, Founders Circle Capital and 127 Others
- Latest Funding Round: Series L, Jul 17, 2026, $*****
- Highlight: Editors' Pick
2. Ayar Labs
Developer of optical interconnect solutions for artificial intelligence infrastructure applications. The company provides optical I/O chiplets and light sources for enhanced bandwidth and power efficiency. These solutions aim to improve the performance and scalability of AI and high-performance computing systems. The company's products are intended for use in data centers and other advanced technology applications.
Key facts about Ayar Labs
- Founded Year: 2015
- Location: San Jose (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $1.02B
- Employee Count: 259 as on Sep 30, 2026
- Investors: Intel, Rising Tide Fund and 58 Others
- Latest Funding Round: Series E, Sep 10, 2026, $*****
- Highlight: Editors' Pick
Developer of cell-based therapies to treat intractable neurological diseases. It generate therapeutic compositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. It offers NRTX-1001, an inhibitory neuron therapy for epilepsy by GABAergic inhibition, reduce seizure activity, and repair the affected neural network.
Key facts about Neurona Therapeutics
- Founded Year: 2008
- Location: San Francisco (United States)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $418M
- Employee Count: 120 as on Sep 30, 2026
- Investors: Fidelity Investments, Topspin Fund and 15 Others
- Latest Funding Round: Series E, Mar 28, 2025, $*****
- Highlight: Acquired
4. Resemble AI
Resemble provides AI-based voice duplication systems. It provides solutions to cloning, languages, games, smart assistant, and digital characters. It provides voice content that can be consumed via Web or API.
Key facts about Resemble AI
- Founded Year: 2019
- Location: Santa Clara (United States)
- Stage: Series B
- Total Funding till date: $25M
- Employee Count: 34 as on Sep 30, 2026
- Investors: Javelin Venture Partners, Craft Ventures and 16 Others
- Latest Funding Round: Series B, Mar 16, 2026, $*****
- Highlight: Editors' Pick
5. Mammoth
Mammoth Biosciences offers a CRISPR data platform for diagnostics using Cas12 and Cas13 proteins. The company is creating a new class of diagnostics for industries ranging from oil and gas to agriculture to healthcare. The platform is used to identify disease-causing biomarkers (DNA/RNA).
Key facts about Mammoth
- Founded Year: 2017
- Location: Brisbane (United States)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $271M
- Employee Count: 159 as on Sep 30, 2026
- Investors: Foresite Capital, AME Cloud Ventures and 34 Others
- Latest Funding Round: Series D, Sep 09, 2021, $*****
- Highlight: Editors' Pick
Berkeley's Year-on-Year Investment Trends
Berkeley has invested in 9 companies over the last 4 years, with an average of 1 new investment annually in the last 3 years. In 2025, it made 1 investment, while as of Jan 2026, it has made 2 investments in this year. Its most recent first time investment was in Datalinx.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 0 | 2 |
2025 | 1 | 0 | 1 |
2024 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 |
2022 | 1 | 0 | 1 |
Berkeley's Investments by Stage
Berkeley has made 1 investment in Seed stage with an average round size of $4.2M, 1 investment in Series A stage with an average round size of $10M, 1 investment in Series B stage with an average round size of $13M and 1 investment in Series C stage with an average round size of $130M.Stage of entry | No. of Investments |
|---|---|
Seed | 1 |
Series A | 1 |
Series B | 1 |
Series C | 1 |
Note: We have considered here, only first round of investments
Berkeley's Investments by Sector
Berkeley has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech, Life Sciences and Semiconductors. Notably, it has invested in 8 Enterprise (B2B) companies, 8 Tech companies, 5 Software companies and at least 2 companies focusing on AI-Native.Sector | No. of Investments |
|---|---|
Enterprise Applications | 2 |
High Tech | 2 |
Life Sciences | 1 |
Semiconductors | 1 |
Note: We have considered here, only first round of investments
Berkeley's Investments by Geography
Berkeley has made most investments in United States (4).Berkeley's recent investments
Berkeley has made 2 investments in 2026 so far - Datalinx and VivereTx.Here are the most recent investments by Berkeley:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 29, 2026 | United States | Seed | 4409 | [+5] | |
Jan 14, 2026 | United States | Series A | 2229 | [+3] | |
Dec 08, 2025 | United States | Series B | 4406 | [+10] | |
Apr 26, 2022 | United States | Series C | 6369 |
Unicorns in Berkeley's Portfolio
Berkeley has 2 unicorns in its portfolio - Ayar Labs and Mammoth. The most recent unicorn in their portfolio is Ayar Labs. It became a unicorn in 2024, 2 years after Berkeley first invested in it.Here is a list of unicorns in Berkeley's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
73 | Developer of optical interconnect solutions for artificial intelligence infrastructure applications | 2015 | San Jose | Series E | ide{jbt | ||
60 | Provider of molecular diagnostics platform by using CRISPR technology | 2017 | Brisbane | Series D | syuphbp |
Acquired companies in Berkeley's Portfolio
1 company from Berkeley's portfolio has been acquired. The most recent acquisition was Neurona Therapeutics in Apr 2026 by UCB for $*****.Here are Berkeley's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 21, 2026 | - | - | 6753 |
Team profile of Berkeley
Berkeley has a team of 29 members including 1 Partner, 8 Venture Partners and 2 Principals located in United States and China. Berkeley's team does not sit on the board of any company as of now.Here is a list of top team members in Berkeley:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | San Francisco | - | ||
Venture Partner | San Francisco | - | - | |
Venture Partner | Berkeley | - | - | |
Venture Partner | Brooklyn | - | - | |
Venture Partner | - | - | ||
Venture Partner | Berkeley | - | - | |
Venture Partner | Hong Kong | - | - | |
Venture Partner | Hong Kong | - | - | |
Venture Partner | Hayward | - | ||
Principal | California | - | ||
Principal | Berkeley | - |
Co-investors of Berkeley
Over the past 4 years, 70 investors have co-invested in Berkeley's portfolio companies. This includes funds and angels.
- Invested before Berkeley: Lockheed Martin, GF and 21 others have invested in rounds before Berkeley. There is 1 company where Lockheed Martin has invested before Berkeley and 1 company where GF has invested before Berkeley.
- Top Co-investors of Berkeley: 28 investors entered a company along with Berkeley. These include investors like IAG Capital Partners (2 companies).
- Invested after Berkeley: A total of 19 investors have invested in Berkeley's portfolio after their investments. Top Investors include VentureTech Alliance (1 company), Hewlett Packard Enterprise (1 company) and Advent International (1 company).
Recent News related to Berkeley
•
Datalinx AI Secures $4.2M Seed Round to Tackle Data Readiness Issues for Enterprise MarketingBenzinga•Jan 29, 2026•High Alpha, Databricks, Datalinx, AperiamVentures and 1 other
•
Vivere Oncotherapies Raises Over $10M in FundingFinSMEs•Jan 14, 2026•Berkeley, National Cancer Institute, FreeFlow, Pillar VC and 1 other
•
Resemble AI Raises $13M From Sony Innovation Fund, Okta Ventures and Others to Tackle AI-Generated Threats as Deepfake Cyberattacks Surge Against Global EnterprisesAccess Newswire•Dec 08, 2025•Okta, Gentree, KDDI, Craft Ventures and 10 others
•
Ysios Capital invests in Neurona Therapeutics' $120 million Series ECapital-Riesgo.es•Feb 09, 2024•Ysios Capital, Neurona Therapeutics, Viking Global Investors, Cormorant Asset Management and 15 others
•
•
Berkeley Frontier Fund launches to invest in highest-profile Berkeley-founded startups; aims to donate $25 million to UC BerkeleyTechStartups.com•May 05, 2022•Berkeley
•
Ayar Labs Raises $130 Million in Series C FundingTelecomDrive•Apr 27, 2022•Ayar Labs, Boardman Bay Capital Management, Hewlett Packard Enterprise, Nvidia and 22 others
